Dataset Information

The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome.

ABSTRACT: BACKGROUND:Negatively charged very-low-density lipoprotein (VLDL-?) in metabolic syndrome (MetS) patients exerts cytotoxic effects on endothelial cells and atrial myocytes. Atrial cardiomyopathy, manifested by atrial remodeling with a dilated diameter, contributes to atrial fibrillation pathogenesis and predicts atrial fibrillation development. The correlation of VLDL-? with atrial remodeling is unknown. This study investigated the association between VLDL-? and remodeling of left atrium. METHODS:Consecutively, 87 MetS and 80 non-MetS individuals between 23 and 74?years old (50.6% men) without overt cardiovascular diseases were included in the prospective cohort study. Blood samples were collected while fasting and postprandially (at 0.5, 1, 2, and 4?h after a unified meal). VLDL was isolated by ultracentrifugation; the percentile concentration of VLDL-? (%) was determined by ultra-performance liquid chromatography. The correlations of left atrium diameter (LAD) with variables including VLDL-?, LDL-C, HDL-C, triglycerides, glucose, and blood pressure, were analyzed by multiple linear regression models. A hierarchical linear model was conducted to test the independencies of each variable's correlation with LAD. RESULTS:The mean LAD was 3.4?±?0.5?cm in non-MetS subjects and 3.9?±?0.5?cm in MetS patients (P?

SUBMITTER: Lee HC

PROVIDER: S-EPMC7507670 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome.

Lee Hsiang-Chun HC Shin Shyi-Jang SJ Huang Jih-Kai JK Lin Ming-Yen MY Lin Yu-Hsun YH Ke Liang-Yin LY Jiang He-Jiun HJ Tsai Wei-Chung WC Chao Min-Fang MF Lin Yi-Hsiung YH

Lipids in health and disease 20200922 1

<h4>Background</h4>Negatively charged very-low-density lipoprotein (VLDL-χ) in metabolic syndrome (MetS) patients exerts cytotoxic effects on endothelial cells and atrial myocytes. Atrial cardiomyopathy, manifested by atrial remodeling with a dilated diameter, contributes to atrial fibrillation pathogenesis and predicts atrial fibrillation development. The correlation of VLDL-χ with atrial remodeling is unknown. This study investigated the association between VLDL-χ and remodeling of left atrium ...[more]

PMID: 32962696

Similar Datasets

Project description:1. The work reported was designed to provide quantitative information about the capacity of the extrahepatic tissues of the rat to degrade injected VLD lipoproteins (very-low-density lipoproteins, d less than 1.006) to LD lipoproteins (low-density lipoproteins, d 1.006--1.063) and to study the fate of the different VLD-lipoprotein apoproteins during the degradative process. 2. Rat liver VLD lipoproteins, radioactively labelled in their protein moieties, were produced by the perfusion of the organ and were either injected into the circulation of the supradiaphragmatic rats or incubated in rat plasma at 37 degrees C. At a time (75 min) when approx. 90% of the triacylglycerol of the VLD lipoproteins had been hydrolysed the supradiaphragmatic rats were bled and VLD lipoproteins, LD lipoproteins and HD lipoproteins (high-density lipoproteins, d 1.063--1.21) were separated from their plasma and from the plasma incubated in vitro. The apoproteins of each of the lipoprotein classes were resolved by gel-filtration chromatography into three main fractions, designated peaks I, II and III. 3. Incubation of the liver VLD lipoproteins in plasma in vitro led to the transfer of about 30% of the total protein radioactivity to the HD lipoproteins. The transfer mainly involved the peak-II (arginine-rich and/or apo A-I) and peak-III (apo C) proteins. There was also a small transfer of radioactivity (about 5% of the total) to the LD lipoproteins. 4. Injection of the liver VLD lipoproteins into the circulation of the supradiaphragmatic rat resulted in the transfer of about 15% of the total VLD-lipoprotein radioactivity to the LD lipoproteins. The transfer involved mainly the peak-I (apo B) proteins and accounted for about 20% of the total apo B protein radioactivity of the injected VLD lipoproteins. When the endogenous plasma VLD lipoprotein was taken into account the transfer of apo B protein was about 35%. 5. The transfer of peak-II protein radioactivity from the VLD to the HD lipoproteins was greater in the plasma of the supradiaphragmatic rat than in the incubated plasma suggesting that there was a net transfer of peak-II apoproteins during the VLD lipoprotein degradation. The transfer of peak-III protein radioactivity was not greater in the plasma of the supradiaphragmatic rat, but there was a loss of this radioactivity from the circulation.

Dataset Information

The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome.

Publications

The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure